354 related articles for article (PubMed ID: 15470401)
41. Biologists denounce UC role in funding start-up companies.
Lehrman S
Nature; 1993 Mar; 362(6418):283. PubMed ID: 8455707
[No Abstract] [Full Text] [Related]
42. Will the latest UK Research Excellence Framework turn out to be the last?
Nature; 2020 Feb; 578(7795):338. PubMed ID: 32076223
[No Abstract] [Full Text] [Related]
43. Rule change set to cost Britain Framework cash.
Giles J
Nature; 2004 Sep; 431(7006):233. PubMed ID: 15371995
[No Abstract] [Full Text] [Related]
44. California's money woes hit universities.
Anderson C
Nature; 1992 Sep; 359(6391):93. PubMed ID: 1522905
[No Abstract] [Full Text] [Related]
45. Funding: proposals ignore mentoring and teaching.
Bothwell J
Nature; 2006 Jun; 441(7094):690. PubMed ID: 16760954
[No Abstract] [Full Text] [Related]
46. Homeward bound European Union.
Schiermeier Q; Smaglik P
Nature; 2005 Jan; 433(7024):440-1. PubMed ID: 15674297
[No Abstract] [Full Text] [Related]
47. Geneticists question fees for use of patented 'junk' DNA.
Dennis C
Nature; 2003 May; 423(6936):105. PubMed ID: 12736643
[No Abstract] [Full Text] [Related]
48. Is the stimulus working for you?
Freeman R; Block F; Greenberg D; Levi M; Segal AM; Crow M; Teitelbaum MS
Nature; 2009 Oct; 461(7266):876-8. PubMed ID: 19829353
[No Abstract] [Full Text] [Related]
49. Mass resignation forces Italian rethink on university funds.
Abbott A
Nature; 2002 Dec 19-26; 420(6917):722. PubMed ID: 12490896
[No Abstract] [Full Text] [Related]
50. Stanford erupts over indirect costs.
Barinaga M
Science; 1990 Apr; 248(4953):292-4. PubMed ID: 2326639
[No Abstract] [Full Text] [Related]
51. Translational science: a view from a biotechnology investor.
Klausner R
Sci Transl Med; 2010 Jun; 2(34):34ed3. PubMed ID: 20519715
[No Abstract] [Full Text] [Related]
52. Home truths.
Schiermeier Q
Nature; 2003 Jun; 423(6942):900-1. PubMed ID: 12815440
[No Abstract] [Full Text] [Related]
53. Capital collaboration Washington DC.
Russo E
Nature; 2005 Feb; 433(7026):664-5. PubMed ID: 15703754
[No Abstract] [Full Text] [Related]
54. The technology trap.
Gewin V
Nature; 2005 Oct; 437(7061):948-9. PubMed ID: 16222269
[No Abstract] [Full Text] [Related]
55. Japan rolls out elite science funds.
Cyranoski D
Nature; 2010 Apr; 464(7291):966-7. PubMed ID: 20393529
[No Abstract] [Full Text] [Related]
56. Danish biotech centre faces axe.
Abbott A
Nature; 2003 Mar; 422(6928):105. PubMed ID: 12634749
[No Abstract] [Full Text] [Related]
57. What the European Research Council is looking for in applications.
Nowotny H
Bioessays; 2010 Jul; 32(7):545-7. PubMed ID: 20544737
[No Abstract] [Full Text] [Related]
58. University seeks private donations to offset climate funding crunch.
Tollefson J
Nature; 2016 Feb; 530(7588):16-7. PubMed ID: 26842035
[No Abstract] [Full Text] [Related]
59. Companies balk at California's patent rules for stem cell research.
Keim B
Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
[No Abstract] [Full Text] [Related]
60. The scientific impact of nations.
King DA
Nature; 2004 Jul; 430(6997):311-6. PubMed ID: 15254529
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
